During the past decade, Fundacion Scherbovsky conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundacion Scherbovsky" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundacion Scherbovsky" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Fundacion Scherbovsky" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Alzheimer Disease" (2 trials), "Alzheimers Disease" (1 trials), "Asthma" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Fundacion Scherbovsky" in a lesser frequency.

Most popular intervention types in "Fundacion Scherbovsky" are "Drug" (13 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Gantenerumab" (3 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Anastrozole" (1 trials) and "Astegolimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundacion Scherbovsky" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Fundacion Scherbovsky". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fundacion Scherbovsky, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Fundacion Scherbovsky, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".